Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
BMC Cancer|October 29, 2020
Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA dataZhili Zeng, Zebiao Cao, Ying TangOncology Letters|September 24, 2020
Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing dataZhili Zeng, Zebiao Cao, Ying TangPhytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 22, 2024
Gut microbiota mediate the alleviation effect of Xiehuo-Guzheng granules on β cell dedifferentiation in type 2 diabetes mellitusZebiao Cao, Xianzhe Wang, Huijun Liu, et al.Bioscience Reports|December 21, 2020
Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA dataZhili Zeng, Zebiao Cao, Enxin Zhang, et al.Frontiers in Microbiology|March 6, 2025
Gut microbiota mediates the pro-pyroptosis effect of xierezhuyubuxu decoction in hepatocellular carcinomaZhili Zeng, Mingxuan Feng, Fan He, et al.Journal of Ethnopharmacology|August 27, 2020
Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysisZebiao Cao, Zhili Zeng, Baohua Wang, et al.Chinese Medicine|September 16, 2024
The improvement of modified Si-Miao granule on hepatic insulin resistance and glycogen synthesis in type 2 diabetes mellitus involves the inhibition of TNF-α/JNK1/IRS-2 pathway: network pharmacology, molecular docking, and experimental validationZebiao Cao, Xianzhe Wang, Zhili Zeng, et al.Aging|October 4, 2021
Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinomaZhili Zeng, Xiao Jiang, Zhibin Pan, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 7, 2023
Shentao Ruangan formula promotes apoptosis via the E2F2-p53 pathway in hepatocellular carcinomaZhili Zeng, Weichi Jiang, Jun Kan, et al.Pageof 1